Small Methods,
Journal Year:
2022,
Volume and Issue:
7(5)
Published: Nov. 29, 2022
Abstract
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
highly
lethal
and
resistant
to
conventional
therapies,
including
chemo‐,
radio‐,
immunotherapy.
In
this
study,
it
first
determined
that
a
combination
of
dihydroartemisinin
(DHA)
RSL‐3
(a
glutathione
peroxidase
4
(GPX4)
inhibitor)
markedly
induced
ferroptosis
PDAC
tumor
cells.
A
mechanistic
study
revealed
DHA
can
react
with
iron
ions
generate
carbon
radicals
deplete
intracellular
glutathione,
thereby
cumulatively
triggering
the
lipid
peroxidation
cells
RSL‐3‐mediated
GPX4
inhibition.
DHA‐conjugated
amphiphilic
copolymer
subsequently
synthesized,
acidity
oxidation
dual‐responsive
nanoparticles
are
further
engineered
for
tumor‐specific
co‐delivery
RSL‐3.
The
resultant
(PDBA@RSL‐3)
efficiently
induce
in
Panc02
tumor‐bearing
immune‐deficient
mouse
model,
elicit
T‐cell‐based
antitumor
immunity
immune‐competent
model.
PDBA@RSL‐3
programmed
death
ligand
1
blockade
therapy
inhibits
growth
models.
This
may
provide
novel
insights
treatment
ferroptosis‐based
Theranostics,
Journal Year:
2023,
Volume and Issue:
13(15), P. 5386 - 5417
Published: Jan. 1, 2023
Stimuli-activatable
strategies
prevail
in
the
design
of
nanomedicine
for
cancer
theranostics.Upon
exposure
to
endogenous/exogenous
stimuli,
stimuli-activatable
could
be
self-assembled,
disassembled,
or
functionally
activated
improve
its
biosafety
and
diagnostic/therapeutic
potency.A
myriad
tumor-specific
features,
including
a
low
pH,
high
redox
level,
overexpressed
enzymes,
along
with
exogenous
physical
stimulation
sources
(light,
ultrasound,
magnet,
radiation)
have
been
considered
nano-medicinal
products.Recently,
novel
stimuli
explored
elegant
designs
emerged
nanomedicine.In
addition,
multi-functional
theranostic
has
employed
imaging-guided
image-assisted
antitumor
therapy.In
this
review,
we
rationalize
development
clinical
pressing
needs.Stimuli-activatable
self-assembly,
disassembly
functional
activation
approaches
developing
realize
better
efficacy
are
elaborated
state-of-the-art
advances
their
structural
detailed.A
reflection,
status,
future
perspectives
provided.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(14), P. 13195 - 13210
Published: May 31, 2023
Radiotherapy
(RT)
is
one
of
the
important
clinical
treatments
for
local
control
triple-negative
breast
cancer
(TNBC),
but
radioresistance
still
exists.
Ferroptosis
has
been
recognized
as
a
natural
barrier
progression
and
represents
significant
role
RT-mediated
anticancer
effects,
while
simultaneous
activation
ferroptosis
defensive
system
during
RT
limits
synergistic
effect
between
ferroptosis.
Herein,
we
engineered
tumor
microenvironment
(TME)
degradable
nanohybrid
with
dual
radiosensitization
manner
to
combine
induction
high-Z
based
on
metal-organic
frameworks
ferroptosis-augmented
TNBC.
The
encapsulated
l-buthionine-sulfoximine
(BSO)
could
inhibit
glutathione
(GSH)
biosynthesis
peroxidase
4
(GPX4)
inactivation
break
down
system,
delivered
ferrous
ions
act
powerful
executor
via
triggering
Fenton
reaction;
combination
them
induces
potent
ferroptosis,
which
synergize
surface
decorated
Gold
(Au)
NPs-mediated
improve
efficacy.
In
vivo
antitumor
results
revealed
that
significantly
therapeutic
efficacy
antimetastasis
efficiency
combinational
mechanism
RT.
This
work
thus
demonstrated
combining
efficient
through
nanotechnology
was
feasible
promising
strategy
TNBC
treatment.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(16), P. 15328 - 15353
Published: Aug. 13, 2023
Ferroptosis,
a
type
of
regulated
cell
death
driven
by
iron-dependent
phospholipid
peroxidation,
has
captured
much
attention
in
the
field
nanomedicine
since
it
was
coined
2012.
Compared
with
other
modes
such
as
apoptosis
and
pyroptosis,
ferroptosis
many
distinct
features
molecular
mechanisms
cellular
morphology,
representing
promising
strategy
for
treating
cancers
that
are
resistant
to
conventional
therapeutic
modalities.
Moreover,
recent
insights
collectively
reveal
is
tightly
connected
maintenance
tumor
immune
microenvironment
(TIME),
suggesting
potential
application
therapies
evoking
robust
antitumor
immunity.
From
biochemical
perspective,
intricately
multiple
metabolic
pathways,
including
iron
metabolism,
lipid
redox
etc.,
highlighting
importance
elucidate
relationship
between
metabolism
developing
therapies.
In
this
review,
we
provide
comprehensive
discussion
on
current
understanding
ferroptosis-inducing
thoroughly
discuss
various
traits
tumors,
which
offer
opportunities
direct
inhibition
through
nanointegrated
approach.
Extending
from
complex
impact
TIME,
also
discussed
those
important
considerations
development
ferroptosis-based
immunotherapy,
challenges
strategies
enhance
ferroptosis-enabled
immunostimulatory
effects
while
avoiding
side
effects.
We
envision
study
may
facilitate
translation
nanomedicines
treatment.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(17), P. 10979 - 11024
Published: April 18, 2024
Nanomaterials
have
attractive
physicochemical
properties.
A
variety
of
nanomaterials
such
as
inorganic,
lipid,
polymers,
and
protein
nanoparticles
been
widely
developed
for
nanomedicine
via
chemical
conjugation
or
physical
encapsulation
bioactive
molecules.
Superior
to
traditional
drugs,
nanomedicines
offer
high
biocompatibility,
good
water
solubility,
long
blood
circulation
times,
tumor-targeting
Capitalizing
on
this,
several
nanoformulations
already
clinically
approved
many
others
are
currently
being
studied
in
clinical
trials.
Despite
their
undoubtful
success,
the
molecular
mechanism
action
vast
majority
remains
poorly
understood.
To
tackle
this
limitation,
herein,
review
critically
discusses
strategy
applying
multiomics
analysis
study
nanomedicines,
named
nanomedomics,
including
advantages,
applications,
future
directions.
comprehensive
understanding
could
provide
valuable
insight
therefore
foster
development
translation
nanomedicines.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Jan. 26, 2024
Abstract
A
wearable
biological
patch
capable
of
producing
multiple
responses
to
light
and
electricity
without
interfering
with
daily
activities
is
highly
desired
for
skin
cancer
treatment,
but
remains
a
key
challenge.
Herein,
the
skin-mountable
electrostimulation-augmented
photothermal
(eT-patch)
comprising
transparent
ionic
gel
MXene
(Ti
3
C
2
T
x)
doping
developed
applied
treatment
melanoma
under
photostimulation
at
0.5
W/cm
.
The
eT-patch
designed
has
superior
electrical
characteristics
owing
gels
doped
which
provides
high
conversion
efficiency
conductivity
as
medium.
Simultaneously,
gel-based
having
excellent
optical
transparency
actualizes
real-time
observation
response
process
stimulation
(PES)
co-therapy.
Systematical
cellular
study
on
anti-tumor
mechanism
PES
revealed
that
can
synergically
trigger
cell
apoptosis
pyroptosis,
together
lead
death
cells.
Due
obvious
advantages
relatively
safe
less
side
effects
in
healthy
organs,
promising
cost-effective
therapeutic
strategy
tumors
will
open
new
avenue
biomedical
applications
gels.
Chemical Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 14, 2025
Ferroptosis,
an
iron-dependent
form
of
regulatory
cell
death,
has
garnered
significant
interest
as
a
therapeutic
target
in
cancer
treatment
due
to
its
distinct
characteristics,
including
lipid
peroxide
generation
and
redox
imbalance.
However,
clinical
application
oncology
is
currently
limited
by
issues
such
suboptimal
efficacy
potential
off-target
effects.
The
advent
nanotechnology
provided
new
way
for
overcoming
these
challenges
through
the
development
activatable
magnetic
nanoparticles
(MNPs).
These
innovative
MNPs
are
designed
improve
specificity
ferroptosis
induction.
This
Review
delves
into
chemical
biological
principles
guiding
design
ferroptosis-based
therapies
imaging-guided
therapies.
It
discusses
mechanisms
attributes
ferroptosis,
composition
MNPs,
their
mechanism
action
inducers,
integration
with
advanced
imaging
techniques
monitoring.
Additionally,
we
examine
convergence
other
strategies,
chemodynamic
therapy,
photothermal
photodynamic
sonodynamic
immunotherapy,
within
context
nanomedicine
strategies
utilizing
MNPs.
highlights
multifunctional
surpass
limitations
conventional
treatments,
envisioning
future
drug-resistance-free,
precision
diagnostics
treating
recalcitrant
cancers.
Journal of the American Chemical Society,
Journal Year:
2022,
Volume and Issue:
145(1), P. 160 - 170
Published: Dec. 21, 2022
Ferroptosis
provides
an
innovative
theoretical
basis
and
method
for
tumor
therapy
but
is
limited
by
the
low
efficiency
of
conventional
iron
delivery
systems.
Herein,
efficient
supramolecular
system
(SIDS)
demonstrated
upon
hydrolysis
FeCl3,
condensation
amino
acids,
self-assembly
iron-containing
components.
The
as-assembled
SIDS
possesses
a
shuttle-like
core/shell
structure
with
β-FeOOH
as
core
Fe3+/polyamino
acid
coordinated
networks
shells.
content
up
to
42
wt
%,
which
greatly
higher
than
that
ferritin.
protein-mimic
morphology
facilitate
accumulation
cell
internalization.
Once
exposed
microenvironment
overexpressed
glutathione
(GSH),
will
disassemble,
accompanied
depletion
GSH
release
Fe2+,
leading
dual
amplified
ferroptosis.
Primary
studies
indicate
exhibits
outstanding
antitumor
efficacy
on
bladder
cancer.
Regenerative Biomaterials,
Journal Year:
2023,
Volume and Issue:
10
Published: Jan. 1, 2023
Abstract
Ferroptosis,
a
completely
new
form
of
regulated
cell
death,
is
mainly
caused
by
an
imbalance
between
oxidative
damage
and
reductive
protection
has
shown
great
anti-cancer
potential.
However,
existing
small-molecule
ferroptosis
inducers
have
various
limitations,
such
as
poor
water
solubility,
drug
resistance
low
targeting
ability,
hindering
their
clinical
applications.
Nanotechnology
provides
opportunities
for
ferroptosis-driven
tumor
therapy.
Especially,
stimuli-responsive
nanomaterials
stand
out
among
others
been
widely
researched
because
unique
spatiotemporal
control
advantages.
Therefore,
it’s
necessary
to
summarize
the
application
those
in
ferroptosis.
Here,
we
describe
physiological
feature
illustrate
current
challenges
induce
cancer
Then,
that
are
classified
elaborated
according
external
internal
stimuli.
Finally,
future
perspectives
field
proposed.
We
hope
this
review
facilitates
paving
way
design
intelligent
nano-ferroptosis
inducers.
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(28)
Published: Aug. 7, 2023
Abstract
Cuproptosis,
a
kind
of
newly
recognized
cell
death
modality,
shows
enormous
prospect
in
cancer
treatment.
The
inducer
cuproptosis
has
more
advantages
tumor
therapy,
especially
that
can
trigger
and
chemodynamic
therapy
(CDT)
simultaneously.
However,
is
restricted
to
the
deficiency
intracellular
copper
ions
nonspecific
delivery
copper‐based
ionophores.
Therefore,
high
level
delivery,
responsive
release,
utilizing
synergistic‐function
become
key
on
cuproptosis‐based
oncotherapy.
In
this
work,
cascade
nanosystem
constructed
for
enhanced
CDT.
weak
acidic
environment
cells,
DNA,
zinc
ions,
Cu
+
release
from
nanosystem.
Since
having
superior
performance
mediating
both
Fenton‐like
reaction
cuproptosis,
released
induces
CDT
efficiently,
accompanied
by
2+
generation.
Then
be
converted
into
partially
glutathione
(GSH)
supply
loop
ensure
synergistic
action.
Meanwhile,
consumption
GSH
also
contributes
return.
Finally,
DNA
Zn
form
DNAzyme
shear
catalase‐related
RNA,
resulting
accumulation
hydrogen
peroxide
further
enhancing
combination
therapy.
These
results
provide
promising
nanotherapeutic
platform
may
inspire
design
potential
treatment
based
cuproptosis.